Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$2.48 - $3.79 $567 - $867
-229 Reduced 13.12%
1,516 $4,000
Q2 2023

Aug 08, 2023

BUY
$2.22 - $3.54 $250 - $400
113 Added 6.92%
1,745 $4,000
Q1 2023

May 12, 2023

SELL
$2.24 - $4.76 $10,115 - $21,496
-4,516 Reduced 73.45%
1,632 $3,000
Q4 2022

Feb 13, 2023

BUY
$2.17 - $35.84 $13,341 - $220,344
6,148 New
6,148 $21,000
Q2 2022

Aug 09, 2022

SELL
$16.5 - $30.34 $18,150 - $33,374
-1,100 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$16.72 - $26.99 $6,972 - $11,254
-417 Reduced 27.49%
1,100 $29,000
Q4 2021

Feb 11, 2022

SELL
$16.93 - $26.82 $32,167 - $50,958
-1,900 Reduced 55.6%
1,517 $34,000
Q3 2021

Nov 09, 2021

BUY
$21.86 - $34.77 $74,695 - $118,809
3,417 New
3,417 $89,000

Others Institutions Holding RLMD

About RELMADA THERAPEUTICS, INC.


  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $10.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.